ADORA3
MOLECULAR TARGETadenosine A3 receptor
ADORA3 (adenosine A3 receptor) is targeted by 42 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ADORA3
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
About ADORA3 as a Drug Target
ADORA3 (adenosine A3 receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 42 compounds with documented ADORA3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ADORA3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.